Status:
COMPLETED
Assessing Impact of CCO's PSO & PC Pathway in Ambulatory HNC Clinics
Lead Sponsor:
Sunnybrook Health Sciences Centre
Conditions:
Head and Neck Cancer
Supportive Care
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Rates of depression and anxiety in cancer patients are much higher compared to the general population. 40% of head and neck cancer patients will develop significant distress along the cancer journey. ...
Detailed Description
Head and neck cancer (HNC) is the sixth most commonly diagnosed cancer worldwide. Individuals with HNC experience a high burden of symptom-related distress (e.g. emotional, physical, psychological, sp...
Eligibility Criteria
Inclusion
- Consenting ambulatory OCC HNC patients, with baseline ESAS scores of \>2 (emotional) or \>3 (physical symptoms) with no active suicidal ideation, cognitive impairment or significant debilitation such that participation would be burdensome for participants and/or safety concerns as determined by a research assistant.
Exclusion
- If participants endorse thoughts of dying at baseline, they will be asked to complete semi-structured questions to assess suicidal ideation (SI). If there is any active SI or intent, the oncology team will be informed, a record kept and the participant will be withdrawn from the study.
Key Trial Info
Start Date :
October 10 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 3 2019
Estimated Enrollment :
98 Patients enrolled
Trial Details
Trial ID
NCT03266276
Start Date
October 10 2017
End Date
December 3 2019
Last Update
January 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada, M4N3M5